Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
5 hedge funds and large institutions have $548K invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
184% more capital invested
Capital invested by funds: $193K → $548K (+$355K)
25% more funds holding
Funds holding: 4 → 5 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$217K |
| 2 |
Renaissance Technologies
New York
|
+$27.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.32K |
Top Sellers
TLC Hedge Fund Activity: Q1 2021 in Review
5 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q1 2021, worth a combined $548K — up 184% from $193K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TLC positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, adding an estimated $217K.
- 5 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q1 2021, up from 4 in Q4 2020.
- Funds reported $548K of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q1 2021, up 184% quarter-over-quarter.
- 1 fund opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q1 2021 and 0 closed out, a net change of +1 holder.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q1 2021 was Jane Street, an estimated $217K added.
Based on aggregated 13F filings for Q1 2021.